BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 15571254)

  • 1. 6-Shogaol Inhibits Oxidative Stress-Induced Rat Vascular Smooth Muscle Cell Apoptosis by Regulating OXR1-p53 Axis.
    Liu J; Li B; Li W; Pan T; Diao Y; Wang F
    Front Mol Biosci; 2022; 9():808162. PubMed ID: 35174215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis.
    Weng T; Poth JM; Karmouty-Quintana H; Garcia-Morales LJ; Melicoff E; Luo F; Chen NY; Evans CM; Bunge RR; Bruckner BA; Loebe M; Volcik KA; Eltzschig HK; Blackburn MR
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1402-12. PubMed ID: 25358054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease.
    Weng T; Karmouty-Quintana H; Garcia-Morales LJ; Molina JG; Pedroza M; Bunge RR; Bruckner BA; Loebe M; Seethamraju H; Blackburn MR
    FASEB J; 2013 May; 27(5):2013-26. PubMed ID: 23392349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells.
    Ju J; Qi Z; Cai X; Cao P; Huang Y; Wang S; Liu N; Chen Y
    PLoS One; 2012; 7(12):e52536. PubMed ID: 23300702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
    Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
    Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
    Staub M
    Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
    Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
    Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes.
    Sasvári-Székely M; Spasokoukotskaja T; Szóke M; Csapó Z; Turi A; Szántó I; Eriksson S; Staub M
    Biochem Pharmacol; 1998 Nov; 56(9):1175-9. PubMed ID: 9802328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis.
    Keszler G; Spasokoukotskaja T; Csapo Z; Virga S; Staub M; Sasvari-Szekely M
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1335-42. PubMed ID: 15571254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological basis for cladribine resistance.
    Lotfi K; Juliusson G; Albertioni F
    Leuk Lymphoma; 2003 Oct; 44(10):1705-12. PubMed ID: 14692522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy.
    Eriksson S; Arnér E; Spasokoukotskaja T; Wang L; Karlsson A; Brosjö O; Gunvén P; Julusson G; Liliemark J
    Adv Enzyme Regul; 1994; 34():13-25. PubMed ID: 7942271
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.